This placental response to obesity may be a compensatory mechanism in response to deficient phospholipid remodeling pathway as indicated by the decreased expression of LPCAT4 in female placentas (Fig. 2C). The gene discussed is LPCAT4; the disease is obesity due to melanocortin 4 receptor deficiency.